Literature DB >> 25456860

Trends in pulmonary valve replacement in children and adults with tetralogy of fallot.

Michael L O'Byrne1, Andrew C Glatz2, Laura Mercer-Rosa2, Matthew J Gillespie3, Yoav Dori3, Elizabeth Goldmuntz3, Steven Kawut4, Jonathan J Rome3.   

Abstract

Operative correction of tetralogy of Fallot frequently results in pulmonary insufficiency and chronic volume overload, which have been linked to increased risk for adverse outcomes. No consensus recommendations for the timing of pulmonary valve replacement (PVR) exist. The aim of this study was to examine the pattern of PVR in the United States from 2004 to 2012. The Pediatric Health Information Systems database was used to perform an observational study of children and adults ≥10 years of age with diagnoses of tetralogy of Fallot who underwent PVR at 35 centers in the United States from 2004 and 2012, to assess the rate of PVR and the age at which is performed. Mixed-effects multivariate regression was used to account for patient-level covariates and center-level covariance. Additional analyses assessed for trends in cost, hospital length of stay (LOS), intensive care unit LOS, and in-hospital mortality over the study period. In total, 799 subjects at 35 centers underwent PVR over the study period. The number of PVRs performed per year increased significantly over the study period. There was significant between-center heterogeneity in age at PVR (p <0.001). Age at PVR, intensive care unit LOS, hospital LOS, and cost did not change over the study period. In conclusion, PVR in patients with tetralogy of Fallot is being performed more frequently, without an accompanying change in the age at PVR or other measurable outcomes. There is significant variability in the age at which PVR is performed among centers across the United States. This highlights the need for additional research guiding the optimal timing of PVR.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2014        PMID: 25456860      PMCID: PMC4262614          DOI: 10.1016/j.amjcard.2014.09.054

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  30 in total

1.  Timing and technique of pulmonary valve replacement in the patient with tetralogy of Fallot.

Authors:  James S Tweddell; Pippa Simpson; Shun-Hwa Li; Jennifer Dunham-Ingle; Peter J Bartz; Michael G Earing; Andrew N Pelech
Journal:  Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu       Date:  2012

2.  Effect of pulmonary valve replacement on left ventricular function in patients with tetralogy of Fallot.

Authors:  Aurélie Chalard; Ingrid Sanchez; Marielle Gouton; Roland Henaine; Fatima A Salami; Jean Ninet; Philippe Charles Douek; Sylvie Di Filippo; Loic Boussel
Journal:  Am J Cardiol       Date:  2012-09-14       Impact factor: 2.778

3.  Cost analysis of percutaneous pulmonary valve replacement.

Authors:  Scott W Gatlin; Dennis W Kim; William T Mahle
Journal:  Am J Cardiol       Date:  2011-05-31       Impact factor: 2.778

4.  Randomized trial of pulmonary valve replacement with and without right ventricular remodeling surgery.

Authors:  Tal Geva; Kimberlee Gauvreau; Andrew J Powell; Frank Cecchin; Jonathan Rhodes; Judith Geva; Pedro del Nido
Journal:  Circulation       Date:  2010-09-14       Impact factor: 29.690

5.  Meta-analysis of pulmonary valve replacement after operative repair of tetralogy of fallot.

Authors:  Eddie Wai-Yin Cheung; Wilfred Hang-Sang Wong; Yiu-Fai Cheung
Journal:  Am J Cardiol       Date:  2010-08-15       Impact factor: 2.778

6.  Corticosteroids and outcome in children undergoing congenital heart surgery: analysis of the Pediatric Health Information Systems database.

Authors:  Sara K Pasquali; Matthew Hall; Jennifer S Li; Eric D Peterson; James Jaggers; Andrew J Lodge; Bradley S Marino; Denise M Goodman; Samir S Shah
Journal:  Circulation       Date:  2010-11-08       Impact factor: 29.690

7.  Adults or big kids: what is the ideal clinical environment for management of grown-up patients with congenital heart disease?

Authors:  Tara Karamlou; Brian S Diggs; Ross M Ungerleider; Karl F Welke
Journal:  Ann Thorac Surg       Date:  2010-08       Impact factor: 4.330

8.  Biventricular response after pulmonary valve replacement for right ventricular outflow tract dysfunction: is age a predictor of outcome?

Authors:  Alessandra Frigiola; Victor Tsang; Catherine Bull; Louise Coats; Sachin Khambadkone; Graham Derrick; Bryan Mist; Fiona Walker; Carin van Doorn; Philipp Bonhoeffer; Andrew M Taylor
Journal:  Circulation       Date:  2008-09-30       Impact factor: 29.690

9.  Current approaches to pulmonary regurgitation.

Authors:  Alessandra Frigiola; Victor Tsang; Johannes Nordmeyer; Philipp Lurz; Carin van Doorn; Andrew M Taylor; Philipp Bonhoeffer; Mark de Leval
Journal:  Eur J Cardiothorac Surg       Date:  2008-06-09       Impact factor: 4.191

10.  Off-label use of cardiovascular medications in children hospitalized with congenital and acquired heart disease.

Authors:  Sara K Pasquali; Matthew Hall; Anthony D Slonim; Kathy J Jenkins; Bradley S Marino; Meryl S Cohen; Samir S Shah
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2008-11-05
View more
  26 in total

1.  Importance of Non-invasive Right and Left Ventricular Variables on Exercise Capacity in Patients with Tetralogy of Fallot Hemodynamics.

Authors:  Christian Meierhofer; Timon Tavakkoli; Andreas Kühn; Kurt Ulm; Alfred Hager; Jan Müller; Stefan Martinoff; Peter Ewert; Heiko Stern
Journal:  Pediatr Cardiol       Date:  2017-08-03       Impact factor: 1.655

2.  4-D flow magnetic-resonance-imaging-derived energetic biomarkers are abnormal in children with repaired tetralogy of Fallot and associated with disease severity.

Authors:  Joshua D Robinson; Michael J Rose; Maria Joh; Kelly Jarvis; Susanne Schnell; Alex J Barker; Cynthia K Rigsby; Michael Markl
Journal:  Pediatr Radiol       Date:  2018-12-01

3.  Earlier Pulmonary Valve Replacement in Down Syndrome Patients Following Tetralogy of Fallot Repair.

Authors:  Rachel T Sullivan; Peter C Frommelt; Garick D Hill
Journal:  Pediatr Cardiol       Date:  2017-06-14       Impact factor: 1.655

4.  Toward predictive modeling of catheter-based pulmonary valve replacement into native right ventricular outflow tracts.

Authors:  Matthew A Jolley; Andras Lasso; Hannah H Nam; Patrick V Dinh; Adam B Scanlan; Alex V Nguyen; Anna Ilina; Brian Morray; Andrew C Glatz; Francis X McGowan; Kevin Whitehead; Yoav Dori; Joseph H Gorman; Robert C Gorman; Gabor Fichtinger; Matthew J Gillespie
Journal:  Catheter Cardiovasc Interv       Date:  2018-11-15       Impact factor: 2.692

5.  Association Between Variation in Preoperative Care Before Arterial Switch Operation and Outcomes in Patients With Transposition of the Great Arteries.

Authors:  Michael L O'Byrne; Andrew C Glatz; Lihai Song; Heather M Griffis; Marisa E Millenson; Matthew J Gillespie; Yoav Dori; Aaron G DeWitt; Christopher E Mascio; Jonathan J Rome
Journal:  Circulation       Date:  2018-11-06       Impact factor: 29.690

6.  Effect of center catheterization volume on risk of catastrophic adverse event after cardiac catheterization in children.

Authors:  Michael L O'Byrne; Andrew C Glatz; Russell T Shinohara; Natalie Jayaram; Matthew J Gillespie; Yoav Dori; Jonathan J Rome; Steven Kawut
Journal:  Am Heart J       Date:  2015-03-03       Impact factor: 4.749

7.  Increasing propensity to pursue operative closure of atrial septal defects following changes in the instructions for use of the Amplatzer Septal Occluder device: An observational study using data from the Pediatric Health Information Systems database.

Authors:  Michael L O'Byrne; Russell T Shinohara; Elena K Grant; Joshua P Kanter; Matthew J Gillespie; Yoav Dori; Jonathan J Rome; Andrew C Glatz
Journal:  Am Heart J       Date:  2017-07-19       Impact factor: 4.749

8.  Operator-Directed Procedural Sedation in the Congenital Cardiac Catheterization Laboratory.

Authors:  Michael L O'Byrne; Marisa E Millenson; James M Steven; Matthew J Gillespie; Yoav Dori; Andrew C Glatz; Jonathan J Rome
Journal:  JACC Cardiovasc Interv       Date:  2019-04-10       Impact factor: 11.195

9.  The influence of deficient retro-aortic rim on technical success and early adverse events following device closure of secundum atrial septal defects: An Analysis of the IMPACT Registry®.

Authors:  Michael L O'Byrne; Matthew J Gillespie; Kevin F Kennedy; Yoav Dori; Jonathan J Rome; Andrew C Glatz
Journal:  Catheter Cardiovasc Interv       Date:  2016-05-18       Impact factor: 2.692

10.  Right Ventricular Outflow Tract Reintervention in the Transcatheter Era: Outcomes and Cost Analysis.

Authors:  Danielle Crethers; Joshua Kalish; Brendan Shafer; Lauren Mathis; Anastasios C Polimenakos
Journal:  Pediatr Cardiol       Date:  2020-01-02       Impact factor: 1.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.